Report Detail

Request for Sample of this report

Other Global Chronic Obstructive Pulmonary Disease Treatment Drug Market 2025 by Company, Regions, Type and Application, Forecast to 2031

  • RnM4626442
    • |
  • 10 September, 2025
    • |
  • Global
    • |
  • 113 Pages
    • |
  • GIR
    • |
  • Other

According to our (Global Info Research) latest study, the global Chronic Obstructive Pulmonary Disease Treatment Drug market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Chronic Obstructive Pulmonary Disease Treatment Drug market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Chronic Obstructive Pulmonary Disease Treatment Drug market size and forecasts, in consumption value ($ Million), 2020-2031
Global Chronic Obstructive Pulmonary Disease Treatment Drug market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Chronic Obstructive Pulmonary Disease Treatment Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Chronic Obstructive Pulmonary Disease Treatment Drug market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Chronic Obstructive Pulmonary Disease Treatment Drug
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Chronic Obstructive Pulmonary Disease Treatment Drug market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GSK, Novartis, Merck, Abbott, Boehringer Ingelheim, AstraZeneca, Roche, Teva, Vectura, Pfizer, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Chronic Obstructive Pulmonary Disease Treatment Drug market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Bronchodilators
PDE-4 Inhibitors
Steroids
Others
Market segment by Application
Hospital
Clinic
Others
Market segment by players, this report covers
GSK
Novartis
Merck
Abbott
Boehringer Ingelheim
AstraZeneca
Roche
Teva
Vectura
Pfizer
Mylan
Allergan
Cipla
Akorn
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Chronic Obstructive Pulmonary Disease Treatment Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Chronic Obstructive Pulmonary Disease Treatment Drug, with revenue, gross margin, and global market share of Chronic Obstructive Pulmonary Disease Treatment Drug from 2020 to 2025.
Chapter 3, the Chronic Obstructive Pulmonary Disease Treatment Drug competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Chronic Obstructive Pulmonary Disease Treatment Drug market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Chronic Obstructive Pulmonary Disease Treatment Drug.
Chapter 13, to describe Chronic Obstructive Pulmonary Disease Treatment Drug research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Chronic Obstructive Pulmonary Disease Treatment Drug by Type
    • 1.3.1 Overview: Global Chronic Obstructive Pulmonary Disease Treatment Drug Market Size by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Global Chronic Obstructive Pulmonary Disease Treatment Drug Consumption Value Market Share by Type in 2024
    • 1.3.3 Bronchodilators
    • 1.3.4 PDE-4 Inhibitors
    • 1.3.5 Steroids
    • 1.3.6 Others
  • 1.4 Global Chronic Obstructive Pulmonary Disease Treatment Drug Market by Application
    • 1.4.1 Overview: Global Chronic Obstructive Pulmonary Disease Treatment Drug Market Size by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Hospital
    • 1.4.3 Clinic
    • 1.4.4 Others
  • 1.5 Global Chronic Obstructive Pulmonary Disease Treatment Drug Market Size & Forecast
  • 1.6 Global Chronic Obstructive Pulmonary Disease Treatment Drug Market Size and Forecast by Region
    • 1.6.1 Global Chronic Obstructive Pulmonary Disease Treatment Drug Market Size by Region: 2020 VS 2024 VS 2031
    • 1.6.2 Global Chronic Obstructive Pulmonary Disease Treatment Drug Market Size by Region, (2020-2031)
    • 1.6.3 North America Chronic Obstructive Pulmonary Disease Treatment Drug Market Size and Prospect (2020-2031)
    • 1.6.4 Europe Chronic Obstructive Pulmonary Disease Treatment Drug Market Size and Prospect (2020-2031)
    • 1.6.5 Asia-Pacific Chronic Obstructive Pulmonary Disease Treatment Drug Market Size and Prospect (2020-2031)
    • 1.6.6 South America Chronic Obstructive Pulmonary Disease Treatment Drug Market Size and Prospect (2020-2031)
    • 1.6.7 Middle East & Africa Chronic Obstructive Pulmonary Disease Treatment Drug Market Size and Prospect (2020-2031)

2 Company Profiles

  • 2.1 GSK
    • 2.1.1 GSK Details
    • 2.1.2 GSK Major Business
    • 2.1.3 GSK Chronic Obstructive Pulmonary Disease Treatment Drug Product and Solutions
    • 2.1.4 GSK Chronic Obstructive Pulmonary Disease Treatment Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 GSK Recent Developments and Future Plans
  • 2.2 Novartis
    • 2.2.1 Novartis Details
    • 2.2.2 Novartis Major Business
    • 2.2.3 Novartis Chronic Obstructive Pulmonary Disease Treatment Drug Product and Solutions
    • 2.2.4 Novartis Chronic Obstructive Pulmonary Disease Treatment Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Novartis Recent Developments and Future Plans
  • 2.3 Merck
    • 2.3.1 Merck Details
    • 2.3.2 Merck Major Business
    • 2.3.3 Merck Chronic Obstructive Pulmonary Disease Treatment Drug Product and Solutions
    • 2.3.4 Merck Chronic Obstructive Pulmonary Disease Treatment Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Merck Recent Developments and Future Plans
  • 2.4 Abbott
    • 2.4.1 Abbott Details
    • 2.4.2 Abbott Major Business
    • 2.4.3 Abbott Chronic Obstructive Pulmonary Disease Treatment Drug Product and Solutions
    • 2.4.4 Abbott Chronic Obstructive Pulmonary Disease Treatment Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Abbott Recent Developments and Future Plans
  • 2.5 Boehringer Ingelheim
    • 2.5.1 Boehringer Ingelheim Details
    • 2.5.2 Boehringer Ingelheim Major Business
    • 2.5.3 Boehringer Ingelheim Chronic Obstructive Pulmonary Disease Treatment Drug Product and Solutions
    • 2.5.4 Boehringer Ingelheim Chronic Obstructive Pulmonary Disease Treatment Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Boehringer Ingelheim Recent Developments and Future Plans
  • 2.6 AstraZeneca
    • 2.6.1 AstraZeneca Details
    • 2.6.2 AstraZeneca Major Business
    • 2.6.3 AstraZeneca Chronic Obstructive Pulmonary Disease Treatment Drug Product and Solutions
    • 2.6.4 AstraZeneca Chronic Obstructive Pulmonary Disease Treatment Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 AstraZeneca Recent Developments and Future Plans
  • 2.7 Roche
    • 2.7.1 Roche Details
    • 2.7.2 Roche Major Business
    • 2.7.3 Roche Chronic Obstructive Pulmonary Disease Treatment Drug Product and Solutions
    • 2.7.4 Roche Chronic Obstructive Pulmonary Disease Treatment Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Roche Recent Developments and Future Plans
  • 2.8 Teva
    • 2.8.1 Teva Details
    • 2.8.2 Teva Major Business
    • 2.8.3 Teva Chronic Obstructive Pulmonary Disease Treatment Drug Product and Solutions
    • 2.8.4 Teva Chronic Obstructive Pulmonary Disease Treatment Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Teva Recent Developments and Future Plans
  • 2.9 Vectura
    • 2.9.1 Vectura Details
    • 2.9.2 Vectura Major Business
    • 2.9.3 Vectura Chronic Obstructive Pulmonary Disease Treatment Drug Product and Solutions
    • 2.9.4 Vectura Chronic Obstructive Pulmonary Disease Treatment Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Vectura Recent Developments and Future Plans
  • 2.10 Pfizer
    • 2.10.1 Pfizer Details
    • 2.10.2 Pfizer Major Business
    • 2.10.3 Pfizer Chronic Obstructive Pulmonary Disease Treatment Drug Product and Solutions
    • 2.10.4 Pfizer Chronic Obstructive Pulmonary Disease Treatment Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Pfizer Recent Developments and Future Plans
  • 2.11 Mylan
    • 2.11.1 Mylan Details
    • 2.11.2 Mylan Major Business
    • 2.11.3 Mylan Chronic Obstructive Pulmonary Disease Treatment Drug Product and Solutions
    • 2.11.4 Mylan Chronic Obstructive Pulmonary Disease Treatment Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 Mylan Recent Developments and Future Plans
  • 2.12 Allergan
    • 2.12.1 Allergan Details
    • 2.12.2 Allergan Major Business
    • 2.12.3 Allergan Chronic Obstructive Pulmonary Disease Treatment Drug Product and Solutions
    • 2.12.4 Allergan Chronic Obstructive Pulmonary Disease Treatment Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 Allergan Recent Developments and Future Plans
  • 2.13 Cipla
    • 2.13.1 Cipla Details
    • 2.13.2 Cipla Major Business
    • 2.13.3 Cipla Chronic Obstructive Pulmonary Disease Treatment Drug Product and Solutions
    • 2.13.4 Cipla Chronic Obstructive Pulmonary Disease Treatment Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.13.5 Cipla Recent Developments and Future Plans
  • 2.14 Akorn
    • 2.14.1 Akorn Details
    • 2.14.2 Akorn Major Business
    • 2.14.3 Akorn Chronic Obstructive Pulmonary Disease Treatment Drug Product and Solutions
    • 2.14.4 Akorn Chronic Obstructive Pulmonary Disease Treatment Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.14.5 Akorn Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Chronic Obstructive Pulmonary Disease Treatment Drug Revenue and Share by Players (2020-2025)
  • 3.2 Market Share Analysis (2024)
    • 3.2.1 Market Share of Chronic Obstructive Pulmonary Disease Treatment Drug by Company Revenue
    • 3.2.2 Top 3 Chronic Obstructive Pulmonary Disease Treatment Drug Players Market Share in 2024
    • 3.2.3 Top 6 Chronic Obstructive Pulmonary Disease Treatment Drug Players Market Share in 2024
  • 3.3 Chronic Obstructive Pulmonary Disease Treatment Drug Market: Overall Company Footprint Analysis
    • 3.3.1 Chronic Obstructive Pulmonary Disease Treatment Drug Market: Region Footprint
    • 3.3.2 Chronic Obstructive Pulmonary Disease Treatment Drug Market: Company Product Type Footprint
    • 3.3.3 Chronic Obstructive Pulmonary Disease Treatment Drug Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Chronic Obstructive Pulmonary Disease Treatment Drug Consumption Value and Market Share by Type (2020-2025)
  • 4.2 Global Chronic Obstructive Pulmonary Disease Treatment Drug Market Forecast by Type (2026-2031)

5 Market Size Segment by Application

  • 5.1 Global Chronic Obstructive Pulmonary Disease Treatment Drug Consumption Value Market Share by Application (2020-2025)
  • 5.2 Global Chronic Obstructive Pulmonary Disease Treatment Drug Market Forecast by Application (2026-2031)

6 North America

  • 6.1 North America Chronic Obstructive Pulmonary Disease Treatment Drug Consumption Value by Type (2020-2031)
  • 6.2 North America Chronic Obstructive Pulmonary Disease Treatment Drug Market Size by Application (2020-2031)
  • 6.3 North America Chronic Obstructive Pulmonary Disease Treatment Drug Market Size by Country
    • 6.3.1 North America Chronic Obstructive Pulmonary Disease Treatment Drug Consumption Value by Country (2020-2031)
    • 6.3.2 United States Chronic Obstructive Pulmonary Disease Treatment Drug Market Size and Forecast (2020-2031)
    • 6.3.3 Canada Chronic Obstructive Pulmonary Disease Treatment Drug Market Size and Forecast (2020-2031)
    • 6.3.4 Mexico Chronic Obstructive Pulmonary Disease Treatment Drug Market Size and Forecast (2020-2031)

7 Europe

  • 7.1 Europe Chronic Obstructive Pulmonary Disease Treatment Drug Consumption Value by Type (2020-2031)
  • 7.2 Europe Chronic Obstructive Pulmonary Disease Treatment Drug Consumption Value by Application (2020-2031)
  • 7.3 Europe Chronic Obstructive Pulmonary Disease Treatment Drug Market Size by Country
    • 7.3.1 Europe Chronic Obstructive Pulmonary Disease Treatment Drug Consumption Value by Country (2020-2031)
    • 7.3.2 Germany Chronic Obstructive Pulmonary Disease Treatment Drug Market Size and Forecast (2020-2031)
    • 7.3.3 France Chronic Obstructive Pulmonary Disease Treatment Drug Market Size and Forecast (2020-2031)
    • 7.3.4 United Kingdom Chronic Obstructive Pulmonary Disease Treatment Drug Market Size and Forecast (2020-2031)
    • 7.3.5 Russia Chronic Obstructive Pulmonary Disease Treatment Drug Market Size and Forecast (2020-2031)
    • 7.3.6 Italy Chronic Obstructive Pulmonary Disease Treatment Drug Market Size and Forecast (2020-2031)

8 Asia-Pacific

  • 8.1 Asia-Pacific Chronic Obstructive Pulmonary Disease Treatment Drug Consumption Value by Type (2020-2031)
  • 8.2 Asia-Pacific Chronic Obstructive Pulmonary Disease Treatment Drug Consumption Value by Application (2020-2031)
  • 8.3 Asia-Pacific Chronic Obstructive Pulmonary Disease Treatment Drug Market Size by Region
    • 8.3.1 Asia-Pacific Chronic Obstructive Pulmonary Disease Treatment Drug Consumption Value by Region (2020-2031)
    • 8.3.2 China Chronic Obstructive Pulmonary Disease Treatment Drug Market Size and Forecast (2020-2031)
    • 8.3.3 Japan Chronic Obstructive Pulmonary Disease Treatment Drug Market Size and Forecast (2020-2031)
    • 8.3.4 South Korea Chronic Obstructive Pulmonary Disease Treatment Drug Market Size and Forecast (2020-2031)
    • 8.3.5 India Chronic Obstructive Pulmonary Disease Treatment Drug Market Size and Forecast (2020-2031)
    • 8.3.6 Southeast Asia Chronic Obstructive Pulmonary Disease Treatment Drug Market Size and Forecast (2020-2031)
    • 8.3.7 Australia Chronic Obstructive Pulmonary Disease Treatment Drug Market Size and Forecast (2020-2031)

9 South America

  • 9.1 South America Chronic Obstructive Pulmonary Disease Treatment Drug Consumption Value by Type (2020-2031)
  • 9.2 South America Chronic Obstructive Pulmonary Disease Treatment Drug Consumption Value by Application (2020-2031)
  • 9.3 South America Chronic Obstructive Pulmonary Disease Treatment Drug Market Size by Country
    • 9.3.1 South America Chronic Obstructive Pulmonary Disease Treatment Drug Consumption Value by Country (2020-2031)
    • 9.3.2 Brazil Chronic Obstructive Pulmonary Disease Treatment Drug Market Size and Forecast (2020-2031)
    • 9.3.3 Argentina Chronic Obstructive Pulmonary Disease Treatment Drug Market Size and Forecast (2020-2031)

10 Middle East & Africa

  • 10.1 Middle East & Africa Chronic Obstructive Pulmonary Disease Treatment Drug Consumption Value by Type (2020-2031)
  • 10.2 Middle East & Africa Chronic Obstructive Pulmonary Disease Treatment Drug Consumption Value by Application (2020-2031)
  • 10.3 Middle East & Africa Chronic Obstructive Pulmonary Disease Treatment Drug Market Size by Country
    • 10.3.1 Middle East & Africa Chronic Obstructive Pulmonary Disease Treatment Drug Consumption Value by Country (2020-2031)
    • 10.3.2 Turkey Chronic Obstructive Pulmonary Disease Treatment Drug Market Size and Forecast (2020-2031)
    • 10.3.3 Saudi Arabia Chronic Obstructive Pulmonary Disease Treatment Drug Market Size and Forecast (2020-2031)
    • 10.3.4 UAE Chronic Obstructive Pulmonary Disease Treatment Drug Market Size and Forecast (2020-2031)

11 Market Dynamics

  • 11.1 Chronic Obstructive Pulmonary Disease Treatment Drug Market Drivers
  • 11.2 Chronic Obstructive Pulmonary Disease Treatment Drug Market Restraints
  • 11.3 Chronic Obstructive Pulmonary Disease Treatment Drug Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Chronic Obstructive Pulmonary Disease Treatment Drug Industry Chain
  • 12.2 Chronic Obstructive Pulmonary Disease Treatment Drug Upstream Analysis
  • 12.3 Chronic Obstructive Pulmonary Disease Treatment Drug Midstream Analysis
  • 12.4 Chronic Obstructive Pulmonary Disease Treatment Drug Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Chronic Obstructive Pulmonary Disease Treatment Drug. Industry analysis & Market Report on Chronic Obstructive Pulmonary Disease Treatment Drug is a syndicated market report, published as Global Chronic Obstructive Pulmonary Disease Treatment Drug Market 2025 by Company, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Chronic Obstructive Pulmonary Disease Treatment Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo